|
COG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.520500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.044950E-03 |
| Normal-vs-Stage2 |
8.465900E-02 |
| Normal-vs-Stage3 |
6.912800E-01 |
| Normal-vs-Stage4 |
6.567800E-01 |
| Stage1-vs-Stage2 |
8.367000E-01 |
| Stage1-vs-Stage3 |
3.033800E-01 |
| Stage1-vs-Stage4 |
3.139000E-01 |
| Stage2-vs-Stage3 |
4.468800E-01 |
| Stage2-vs-Stage4 |
4.390000E-01 |
| Stage3-vs-Stage4 |
9.883800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.903200E-03 |
| Normal-vs-AfricanAmerican |
8.536400E-02 |
| Normal-vs-Asian |
3.587400E-01 |
| Caucasian-vs-AfricanAmerican |
6.039400E-01 |
| Caucasian-vs-Asian |
7.423600E-01 |
| AfricanAmerican-vs-Asian |
5.699400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.655100E-03 |
| Normal-vs-Female |
3.645000E-01 |
| Male-vs-Female |
9.715600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.846400E-02 |
| Normal-vs-Extreme_Weight |
3.557800E-03 |
| Normal-vs-Obese |
5.974100E-02 |
| Normal-vs-Extreme_Obese |
3.906200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.017800E-01 |
| Normal_Weight-vs-Obese |
6.192000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.346600E-01 |
| Extreme_Weight-vs-Obese |
3.636400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.962400E-01 |
| Obese-vs-Extreme_Obese |
9.518800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.773800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.711970E-01 |
| Normal-vs-Age(61-80Yrs) |
4.019800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.363970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.410000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.091800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.965700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.203960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.949770E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.082000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.332300E-02 |
| Normal-VS-Type2 PRCC |
7.743500E-02 |
| Normal-VS-KIRP CIMP |
7.507800E-02 |
| Normal-VS-Unclassified PRCC |
2.318600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.914400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.822800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.895400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.096200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.988800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.994200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.961100E-03 |
| Normal-vs-N1 |
8.384200E-01 |
| Normal-vs-N2 |
9.084200E-02 |
| N0-vs-N1 |
4.160100E-02 |
| N0-vs-N2 |
9.997600E-01 |
| N1-vs-N2 |
4.198600E-01 |
|
|
